Current research confirms that smoking cessation and weight control can prevent the onset or slow the progression of AMD. For dry AMD, appropriate supplementation with antioxidants, zinc, lutein and zeaxanthin is recommended; for wet AMD, the above preventive measures also have some effect in slowing down the progression of the disease. However, it should be noted that “long-term B-carotene users have a yellowish skin color and an increased risk of lung cancer in current smokers and those who quit within 1 year; zinc use increases the likelihood of hospitalization for genitourinary disease and can lead to copper deficiency anemia; therefore, before considering long-term use of the high doses recommended by AREDS antioxidant vitamins and minerals recommended by AREDS, the patient’s systemic condition should be taken into account”. Yong Liu, Ophthalmology, Air Force General Hospital There is no definitive treatment for dry AMD, and the drugs mentioned above can only provide a certain degree of relief. For the treatment of wet AMD, photodynamic therapy (PDT) has been recommended in the past, but the recurrence rate is high, and one study found that mild to severe bleeding was seen in 22% of patients within 2 weeks after surgery, and moderate or severe visual impairment eventually occurred in 3.8%. Therefore, the current first-line treatment option is intravitreal injection of anti-VEGF analogs.